University of Rochester Eye Institute
Rochester, New York, 14642, United States
NCT Number: NCT00681265
This study is an exploratory trial evaluating the tear film break-up time after a single eye drop instillation of over-the-counter artificial tears. The primary hypothesis is that tear film break up time will be greater for test than control eye.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Rochester, New York, 14642, United States
Subjects with varying degrees of dry eye syndrome were enrolled in a randomized, controlled, double masked, single site study. A new formulation of an artificial tear containing glycerin 1% as an active with polylysine-graft-polyethylene glycol as an excipient was compared against a leading commercial product with propylene glycol (0.3%) and polyethylene glycol (0.4%) as active ingredients with hydroxypropyl-guar as a gelling agent. The primary outcome was a comparison of tear film stability after eye drop instillation.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Eye drop with active agent glycerin 1%, new topical ophthalmic formulation with polylysine-graft-polyethylene glycol as an excipient, single instillation.
Other names: Eyeon Protect(TM)
Eye drop with the active agents polyethylene glycol 400 0.4% /propylene glycol 0.3%, topical ophthalmic formulation, single instillation
Other names: Systane(R)
Time frame: 15 minutes after eye drop instillation
State-of-the-art methodology to assess tear stability.
Time frame: 120 minutes after eye drops instillation
Standard clinical assessment methodology for assessing tear stability.
Calm Water Therapeutics LLC
Industry
A Randomized, Masked Exploratory Trial Comparing the Effect of Two Different Over-the-Counter Artificial Tear Preparations on Tear Film Break-up Time
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00201955
Conjunctival Diseases, Conjunctivitis
Birmingham, Alabama, United States
View Trial DetailsNCT00201981
Conjunctival Diseases, Conjunctivitis
Birmingham, Alabama, United States
View Trial DetailsNCT07422259
Conjunctival Diseases, Conjunctivitis
Messina, Italy
View Trial DetailsNCT03953703
Arthritis, Arthritis, Rheumatoid
Nashville, Tennessee, United States
View Trial Details